July 19, 2024- Abbott announced financial results for the second quarter ended June 30, 2024. During the first half of 2024, Abbott announced 10 new growth opportunities coming from the company's highly productive R&D pipeline. These include a combination of new product approvals and new treatment indications Second-quarter GAAP diluted EPS of $0.74 and adjusted diluted … [Read more...]
Intermountain Health names new members to Board of Trustees
July 19, 2024- Intermountain Health recently welcomed four new members to its Board of Trustees – Mario M. Carrera; Chip Childs; Seraphine Kapsandoy-Jones, PhD, RN; and Randal K. Quarles. “We’re pleased to welcome our four new Board members. They were chosen because of their skills and perspective, their standing in the community, and their ability to lead and govern,” said … [Read more...]
SMI, AHRMM, form UDI Workgroup in partnership with the FDA
July 19, 2024- Strategic Marketplace Initiative (SMI®), the Association for Health Care Resource & Materials Management (AHRMM), have co-developed a collaborative workgroup in an effort to re-energize and re-focus the Unique Device Identification (UDI) system, and to move the industry forward regarding UDI implementation. The UDI system was established in 2013 by the FDA to … [Read more...]
QuidelOrtho to report second quarter 2024 financial results
July 18, 2024- QuidelOrtho Corporation announced that it will report its financial results for its second quarter 2024 ended June 30, 2024, after the market close on Wednesday, July 31, 2024. Following the release of financial results, QuidelOrtho will hold a conference call beginning at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial results. Interested parties can … [Read more...]
More than 3,000 health care organizations recognized for commitment to quality cardiovascular care
July 18, 2024- The American Heart Association is recognizing 3,147 health care and emergency response organizations for their commitment to improving health outcomes for cardiovascular patients through evidence-based efficient and coordinated care. Nearly 500 more sites have demonstrated their earned recognition this year compared with 2023, expanding patient access to … [Read more...]
Kaiser expands Hawaii home health program
July 18, 2024- Kaiser Permanente has expanded its home health agency on Hawaii Island. Kaiser Permanente Home Health agency is geared toward members who rely on assistive devices such as walkers, canes or wheelchairs, and those with health conditions that limit their ability to leave home and necessitate care from skilled nurses or therapists, according to a July 17 … [Read more...]
CAPS Research at ASU appoints new Co-Executive Director for Advanced Purchasing Studies
July 18, 2024- Eugene Schneller, Ph.D., has been appointed as Co-Executive Director of the Center for Advanced Purchasing Studies. Since its founding, CAPS Research has been jointly operated as an applied research center under the auspices of Arizona State University and the Institute for Supply Management® (ISM®) the leadership team reaffirms the commitment of both … [Read more...]
PWH to offer professional development course
July 18, 2024- Join PWH for the 2024 Professional Development Course: “Master Strategic Connection and Influence with Senior Stakeholders," August 9 & 16, from 11AM – 2 PM ET. In this two-session course, unlock your career potential with the power of managing up. It’s about understanding senior leaders, knowing who you are, and connecting and building real relationships … [Read more...]
Cleveland Clinic and Kent State partner to support student-athlete health
July 18, 2024- Cleveland Clinic will serve as the medical services provider to support Kent State student-athlete health and wellness. It will provide a variety of multidisciplinary services, including physicians, athletic training, physical therapy, behavioral health services, sports performance services, medical scheduling and insurance processing. The new partnership also … [Read more...]
Pfizer launches process to identify a Successor for Chief Scientific Officer and President
July 17, 2024- Pfizer Inc. announced that the company is launching the process to identify a successor for Dr. Mikael Dolsten, Pfizer’s Chief Scientific Officer and President, Pfizer Research & Development, who will depart the company after a more than 15-year stellar career. This process is expected to last several months, probably through early next year. Pfizer will … [Read more...]